Merck reported EUR660M in EBIT for its fiscal quarter ending in September of 2026.





Ebit Change Date
Adidas EUR 1.03B 454M Sep/2026
Adyen EUR 570.31M 56.8M Jun/2026
Akzo Nobel EUR -73M 324M Sep/2026
Alcon AG USD 380M 336M Sep/2026
Amadeus IT EUR 527.1M 48.8M Sep/2026
Amarin USD -2.26M 564K Dec/2025
AstraZeneca USD 4.66B 1.5B Sep/2026
BASF EUR 188M 1.25B Sep/2026
Bayer EUR 129M 626M Sep/2026
Beiersdorf EUR 760M 256M Jun/2026
Covestro EUR -324M 5.72B Dec/2025
Danone EUR 1.86B 6M Jun/2026
Fresenius EUR 639M 80M Sep/2026
Fresenius Medical Care EUR 384M 96.55M Sep/2026
Genmab DKK 407M 221M Jun/2026
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.86B 251M Sep/2026
GRIFOLS EUR 394M 34M Sep/2026
Henkel EUR 1.64B 220M Jun/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Infineon EUR 866M 260M Sep/2026
Lakefront Biotherapeutics EUR -41.17M 2.34M Sep/2026
Linde USD 2.2B 294M Sep/2026
Lonza CHF 673M 54M Jun/2025
Merck EUR 660M 437M Sep/2026
Novartis USD 5.14B 411M Sep/2026
Philips EUR 206M 435M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 4.72B 3.6B Sep/2026
UCB EUR 1.29B 571M Dec/2025